Edward Fellows
About Edward Fellows
Edward Fellows is a Patent Examiner in Biotechnology, specializing in vaccines and antibodies at the European Patent Office in Munich, Germany. He has a strong academic background, including a Ph.D. in Biochemistry and Immunology, and has previously worked as a post-doctoral research fellow at the Max Planck Institute of Neurobiology.
Work at European Patent Office
Edward Fellows has been employed at the European Patent Office (EPO) since 2008 as a Patent Examiner in the field of Biotechnology, specifically focusing on Vaccines and Antibodies. His role involves assessing patent applications, ensuring compliance with patent laws, and contributing to the knowledge transfer activities related to biotechnology patents. He has been active in delivering presentations on topics such as 'The patentability of vaccines at the EPO' and 'The vaccines and dynamics of the COVID-19 pandemic'.
Education and Expertise
Edward Fellows has a strong educational background in the life sciences. He obtained a Doctor of Philosophy (PhD) in Biochemistry and Immunology from Ludwig-Maximilians Universität München, where he studied from 2003 to 2007. He also holds a Bachelor of Science with Honors in Cellular and Molecular Biology from the University of Bath, completed from 1996 to 2000. His foundational education includes a Baccalauréat Européen from the European School in Culham, UK, and a Diplôme national du Brevet from Ecole de la Présentation de Marie in France.
Background
Before joining the European Patent Office, Edward Fellows gained significant research experience at the Max Planck Institute of Neurobiology in Martinsreid, Munich. He worked there as a Post-doctoral Research Fellow from 2007 to 2008 and previously as a Research Scientist from 2002 to 2003. Additionally, he completed his PhD studies at the same institute from 2003 to 2007, focusing on Biochemistry and Immunology.
Language Proficiency
Edward Fellows is fluent in English, French, and German, which are the three official languages of the European Patent Office. This language proficiency enables him to effectively communicate and collaborate in a multilingual environment, enhancing his contributions to the EPO's activities in the biotechnology sector.